| Title |
Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies
|
|---|---|
| Published in |
Lancet Oncology, May 2015
|
| DOI | 10.1016/s1470-2045(14)71206-9 |
| Pubmed ID | |
| Authors | |
| Abstract |
Arguably, nowhere has there been a greater advance in our understanding of biological mechanisms and potential translational targets during the next-generation sequencing era than in paediatric brain tumours. The so-called omics revolution, enabled by high-throughput sequencing, has empowered large consortia and independent groups alike to make major genetic discoveries, from dominant-negative histone mutations and hijacking of distal enhancer elements, to new oncogenic gene fusions and aberrantly active gene expression. Epigenetic deregulation has also been revealed as a common theme across several tumour subtypes. This Review focuses on key findings that have been transforming the landscape of paediatric neuro-oncology research and how these results are opening new avenues towards potential therapeutic translation. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 29% |
| Venezuela, Bolivarian Republic of | 1 | 14% |
| France | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Scientists | 2 | 29% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 2 | 1% |
| Portugal | 1 | <1% |
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Germany | 1 | <1% |
| Czechia | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 158 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 37 | 22% |
| Student > Ph. D. Student | 28 | 17% |
| Student > Master | 14 | 8% |
| Student > Doctoral Student | 13 | 8% |
| Other | 11 | 7% |
| Other | 26 | 16% |
| Unknown | 38 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 26% |
| Biochemistry, Genetics and Molecular Biology | 34 | 20% |
| Agricultural and Biological Sciences | 32 | 19% |
| Neuroscience | 10 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 1% |
| Other | 6 | 4% |
| Unknown | 40 | 24% |